KRAS and cervical carcinoma: KRAS mutations constitute a poor prognostic marker in NSCLC and colorectal cancer, however, its prognostic characteristic in cervical cancer remains to be elucidated.44,45 To date, RAS proteins have not yielded successful targeted therapies.